Randi Hagerman
Medical Director
MIND Institute
From this contributor
Diabetes drug delivers multiple benefits for people with fragile X syndrome
Researcher Randi Hagerman is a big proponent of metformin — a diabetes drug that she is testing in people with fragile X syndrome. In fact, Hagerman takes the drug herself as a preventive measure against cancer.
Diabetes drug delivers multiple benefits for people with fragile X syndrome
Drug trials for fragile X syndrome lead the way for autism
Several targeted trials on drugs that treat fragile X syndrome are under way. But accurate endpoints to measure the drugs’ effectiveness are crucial, argues developmental and behavioral pediatrician Randi Hagerman.
Drug trials for fragile X syndrome lead the way for autism
Explore more from The Transmitter
Lipids enter brain mapping limelight
Two new studies, including the first whole-brain lipid atlas in mice, uncover unforeseen complexity and influence during pregnancy and aging.
Lipids enter brain mapping limelight
Two new studies, including the first whole-brain lipid atlas in mice, uncover unforeseen complexity and influence during pregnancy and aging.
Behavioral phenomics in zebrafish; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 26 October.
Behavioral phenomics in zebrafish; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 26 October.
Neuroscience gave AI its start. What happens now?
David Sussillo maps the two fields' divergent paths, and where they might still meet.
Neuroscience gave AI its start. What happens now?
David Sussillo maps the two fields' divergent paths, and where they might still meet.